You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華仁藥業(300110.SZ):擬設西安曲江華仁藥業 推進製藥項目及大健康項目落地
格隆匯 05-21 20:18

格隆匯5月21日丨華仁藥業(300110.SZ)公佈,2021521日,公司第七屆董事會第五次(臨時)會議審議通過《關於對外投資設立子公司的議案》,為積極推進醫藥大健康戰略佈局,提升公司綜合實力,公司擬設立西安曲江華仁藥業有限公司(暫定名),註冊資本5億元人民幣以新設立的公司為主體,通過直接投資或併購的方式,推進製藥項目以及大健康項目落地,並充分發揮西安的區位優勢和資源優勢,加快公司在西北、華東及全國的產業佈局。

為了把握行業變革帶來的戰略發展機遇,公司以新設立的公司為主體,圍繞公司上下游產業鏈,通過直接投資或併購的方式,積極推進醫藥、大健康產品佈局,進一步拓展公司產品線,提升公司研發實力,豐富和完善醫藥品種,通過一系列戰略項目的落地實施,提升公司的核心競爭力,推動公司實現跨越式發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account